Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jolanta, Andrzejuk"'
Autor:
Piotr Rutkowski, Beata Jagielska, Jolanta Andrzejuk, Elzbieta Bylina, Iwona Lugowska, Tomasz Switaj, Hanna Kosela-Paterczyk, Katarzyna Kozak, Slawomir Falkowski, Anna Klimczak
Publikováno v:
Contemporary Oncology, Vol 21, Iss 4, Pp 285-289 (2017)
Aim of the study was to analyze the outcome of treatment and factors predicting results of sorafenib therapy in inoperable/metastatic CD117-positive GIST patients after failure on imatinib and sunitinib. Material and methods : We identified 60 consec
Externí odkaz:
https://doaj.org/article/86e1d9babcf8469d81cd7228127e973e
Autor:
Joanna, Jońska-Gmyrek, Agnieszka, Zółciak-Siwińska, Leszek, Gmyrek, Jagna, Staniaszek, Bogusław, Lindner, Jolanta, Andrzejuk
Publikováno v:
Ginekologia polska. 83(8)
The impact of the tumor size on treatment outcomes in cervical cancer patients remains a subject of controversyThe assessment of prognostic value of pretreatment tumor size in cervical cancer patients.Patients of Maria Sklodowska - Curie Memorial Can
Autor:
Tomasz Świtaj, Agnieszka Woźniak, Monika Jurkowska, Janusz A. Siedlecki, Jolanta Andrzejuk, Elżbieta Bylina, Maria Debiec-Rychter, Urszula Grzesiakowska, Czesław Osuch, Anna Jerzak vel Dobosz, Janusz Limon, Piotr Rutkowski
Publikováno v:
Medical Oncology (Northwood, London, England)
The introduction of imatinib to clinical practice revolutionized therapy of advanced gastrointestinal stromal tumors (GIST), but its long-term results have been only just collected. We have attempted to identify factors related to the long-term survi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1307f3e15f4c25034bbcb068c2a0f592
https://ruj.uj.edu.pl/xmlui/handle/item/109230
https://ruj.uj.edu.pl/xmlui/handle/item/109230
Autor:
Tomasz Kucharczyk, Jolanta Andrzejuk, Beata Biernacka, Dariusz M. Kowalski, Paweł Krawczyk, Janusz Milanowski, Radosław Mlak, Kamila Wojas-Krawczyk
Publikováno v:
Cancer Research. 71:LB-449
Introduction. A rare variant of chromosomal region 15q25.1, marked by rs16969968 (substitution 1354G>A or D398N in CHRNA5 gene), was found to be associated with increased lung cancer risk and nicotine dependence appearance. We attempted to confirm th